Product Images
CAVALIER™ Gentleman's Product Daily Prostate Support - CELLUCOR - GNC Zoom
Product Videos

CAVALIER™ Gentleman's Product Daily Prostate Support

Shop all CAVALIER

Auto-Delivery Available

Sign Up & Save! Enroll in Auto-Delivery and lock in your price for 12 months.

Learn More

Price: $39.99

Member Price: $35.99 Become a Member
Ship every:
Add to Cart

90 Capsules

Item #447649 See Product Details

Price: $39.99

Member Price: $35.99 Become a Member

Availability: In Stock Details

People Who Buy This Also Bought
You May Also Be Interested In
More Sizes Available
Description
CAVALIER™
Gentleman's Product
Daily Prostate Support
For Gentlemen of High Distinction
Exclusively Tailored Formula

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Supplement Facts

TAKE ONE SERVING (3 CAPSULES) ONCE DAILY WITH FOOD. DO NOT EXCEED 6 CAPSULES IN A 24-HOUR PERIOD. USE FOR UP TO 8 WEEKS IN A CYCLE THEN DISCONTINUE USE FOR 4 WEEKS BEFORE STARTING A NEW CYCLE.

Serving Size 3 Capsules
Servings Per Container 30
Amount Per Serving % DV
Vitamin D (as Cholecalciferol) 841.00 IU 210%
Zinc (as Zinc Monomethionine) 30.00 mg 200%
CAVALIER™ Prostate Blend 1423.00 mg **
 Pomegranate (Punica granatum) fruit extract Saw Palmetto (Serenoa repens) fruit extract Lycopene 10% Beadlets **
 Pumpkin (Cucurbita moschata) seed extract Japanese sophora (Sophora japonica bud extract (standardized for Quercetin) **
 Soy bean (Glyine max) seed extract (standardized for Beta Sitosterol) Pygeum (Prunus at africana) bark **
** Daily Value (DV) not established

Other Ingredients: Microcrystalline Cellulose, Silicon Dioxide, Magnesium Stearate, Gelatin, Titanium Dioxide, FD&C Blue #1, FD&C Red #40

Warning: THIS PRODUCT IS ONLY INTENDED FOR HEALTHY ADULT MEN, 18 YEARS OF AGE OR OLDER. NOT FOR USE BY WOMEN, ESPECIALLY THOSE WHO ARE PREGNANT OR NURSING. CONSULT A LICENSED, QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING THIS PRODUCT, INCLUDING BUT NOT LIMITED TO, IF YOU HAVE BEEN TREATED FOR, DIAGNOSED WITH, OR HAVE A FAMILY HISTORY OF ANY MEDICAL CONDITION, INCLUDING BUT NOT LIMITED T0: PROSTATE CANCER OR PROSTATE ENLARGEMENT, OR, IF YOU ARE TAKING ANY OTHER DIETARY SUPPLEMENT, PRESCRIPTION DRUG OR OVER.THE.COUNTER MEDICATION. DO NOT USE THIS PRODUCT IF YOU HAVE ANY SERIOUS MEDICAL CONDITIONS. DISCONTINUE USE 2 WEEKS PRIOR TO SURGERY. IMMEDIATELY DISCONTINUE USE AND CONSULT A LICENSED, QUALIFIED HEALTH CARE PROFESSIONAL IF YOU EXPERIENCE ANY ADVERSE REACTION TO THIS PRODUCT. DO NOT EXCEED RECOMMENDATIONS FOR SUGGESTED USE. DO NOT USE IF SAFETY SEAL IS BROKEN OR MISSING. STORE IN A COOL, DRY PLACE. KEEP OUT OF REACH OF CHILDREN.

Contains: Soy

DISTRIBUTED BY NUTRABOLT. 3891 S. TRADITIONS DR. BRYAN, TX 77807

Health Notes

Omega-3 and Prostate Cancer: A Fishy Connection

Omega-3 and Prostate Cancer: A Fishy Connection
Omega-3 and Prostate Cancer: A Fishy Connection: Main Image
The findings are intriguing, but do not prove a cause-and-effect relationship between omega-3s and prostate cancer risk
Prostate cancer is common in men and can be lethal, causing health experts to continue to look for controllable factors to help reduce risk and maintain health after diagnosis. These include early detection screenings, nutrition, and exercise. Recent headlines have raised alarm that omega-3 fats-specifically from fish oil supplements-may increase prostate cancer risk, yet a closer look at the research clearly shows the results are inconclusive.

A new look at an existing study

The Selenium and Vitamin E Cancer Prevention Trial (known SELECT), was a randomized, placebo-controlled trial that tested whether selenium and vitamin E, alone or combined, reduced prostate cancer risk (they didn't). The men in SELECT were followed closely for several years. They provided blood samples, and information on their diet, health habits, and other lifestyle factors for the study.

From this group, researchers identified 834 men who had been diagnosed with prostate cancer and compared them with 1,393 similar men who had not been diagnosed with prostate cancer. The researchers adjusted for factors that may have differed between the men, including education, history of diabetes, family history of prostate cancer, and what group they had been assigned to in the original SELECT study.

Compared with men who had the lowest levels of omega-3 fatty acids in their blood at the start of the SELECT trial, those who had the highest omega-3 levels were 44% more likely to have been diagnosed with low-grade (less aggressive) prostate cancer, 71% more likely to have been diagnosed with high-grade (more aggressive) prostate cancer, and 43% more likely to have been diagnosed with any type of prostate cancer.

Fishing for answers

These findings were widely reported as a signal that omega-3 supplements are harmful; however, as Alan Gaby, MD, Chief Medical Editor for Aisle7 points out, "This is a case-cohort study, not a controlled trial, and it cannot prove cause and effect. The findings are intriguing, but do not prove a causative pathway between long-chain omega-3s and prostate cancer risk."

Before you drop omega-3 supplements from your self-care plan, consider the following caveats about this new study:

Consider study strength: In addition to being based on case-cohort information, which is a type of study that may provide associations, but not prove causality, SELECT was not originally designed to study connections between omega-3 supplements and prostate cancer risk. This increases the likelihood of reaching erroneous conclusions when the data are analyzed for this connection after the fact. In fact, tracking omega-3 supplement use was not part of the study at all. Further, the study looked backward in time to assess future prostate cancer risk. It is possible that something about the disease process itself caused higher omega-3 blood levels rather than the other way around. Only a controlled trial can prove whether omega-3 supplements increase, decrease, or have no effect on prostate cancer risk.

Consider the big picture: The Mediterranean diet pattern, noted for generous omega-3 fats from a variety of sources, is associated with a significantly decreased prostate cancer risk. Many health experts have noted that if omega-3 fats were associated with increased aggressive prostate cancer risk, you would see more cases of the disease in countries with high fish intake. This is not the case, and notably, men living in many countries with the highest omega-3 intakes, such as Japan, have lower risk of prostate cancer. Though the authors state they are confirming results of their earlier work, other studies have shown no increased prostate cancer risk, and in some cases a decreased risk, with higher intakes of omega-3 fats.

Consider your overall health goals: Among its many science-supported benefits, omega-3 supplements are prescribed to reduce cardiovascular disease risk, and it's notable that the top killer of prostate cancer survivors is heart disease, not prostate cancer. If you take omega-3s to manage heart disease risk, it may not be a good idea to stop, based only on the assertions from this study's results. Talk to your doctor about what is best for you, based on your medical concerns and issues.

(J Natl Cancer Inst; July 10 2013 [Epub ahead of print; accessed July 11 2013])
Suzanne Dixon, MPH, MS, RD, an author, speaker, and internationally recognized expert in chronic disease prevention, epidemiology, and nutrition, has taught medical, nursing, public health, and alternative medicine coursework. She has delivered over 150 invited lectures to health professionals and consumers and is the creator of a nutrition website acclaimed by the New York Times and Time magazine. Suzanne received her training in epidemiology and nutrition at the University of Michigan, School of Public Health at Ann Arbor.
Label
To view the Label you will need Adobe Acrobat Reader installed. You can download a free copy of the Adobe Acrobat Reader at: http://www.adobe.com/acrobat/readstep.html
Ratings and Reviews
Ask A Question